VP, Head of Cell & Genetic Medicines Discovery

MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

Interleukin-23 Inhibitors Market to Surge During the Forecast Period (2025-2034) Due to Demand for Targeted Autoimmune Therapies | DelveInsight

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

Postdoctoral Scientist Real World Evidence (RWE)

Johnson & Johnson Innovative Medicine is a leader in healthcare innovation, dedicated to developing smarter and less invasive treatments. The Postdoctoral Scientist in Real-World Evidence (RWE) Oncology will analyze data to generate insights for regulatory interactions and develop study protocols while effectively communicating findings through reports and publications.

Associate Director, Auto-Anitibody Integrated Analytics

Principal Statistician

Associate Statistical Programmer

Cell Therapy Decisional Analytics Scientist

Sign up with Google

Sign in with Google